Fludrocortisone for the Prevention of Vasovagal Syncope
- 27 June 2016
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 68 (1), 1-9
- https://doi.org/10.1016/j.jacc.2016.04.030
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Pharmacotherapy of autonomic failurePharmacology & Therapeutics, 2012
- Cardiac output and sympathetic vasoconstrictor responses during upright tilt to presyncope in healthy humansJournal Of Physiology-London, 2012
- α‐Adrenoceptor agonists for the treatment of vasovagal syncope: a meta‐analysis of worldwide published dataActa Paediatrica, 2009
- Importance of competing risks in the analysis of anti-epileptic drug failureTrials, 2007
- The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study designAmerican Heart Journal, 2006
- Salt Supplementation Improves Orthostatic Cerebral and Peripheral Vascular Control in Patients With SyncopeHypertension, 2004
- Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope.Heart, 1996
- Neurocardiogenic syncope in children with a normal heartJournal of the American College of Cardiology, 1994
- Events in the cardiac arrhythmia suppression trial (CAST): Mortality in the entire population enrolledJournal of the American College of Cardiology, 1991